Redeye: Orexo - Zubsolv US Sales Data and a DTx Comment

tis, maj 05, 2020 08:03 CET

Redeye brings fresh data about the sales of Zubsolv in the US and a comment on the reimbursement of digital therapies.

Read more and download the Research Update: https://bit.ly/3deJTIU

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/